EpiPen outrage may fuel cheap generic in 2017

Life-saving drugs are getting more expensive

Help for parents outraged by skyrocketing EpiPen prices could be coming as soon as next year.

A generic alternative for the lifesaving allergy treatment is being developed by Teva Pharmaceuticals (TEVA). The company has indicated the generic treatment may arrive as early as next year, creating a cheaper alternative to EpiPen, which has cornered an estimated 94% of the market.

Let’s block ads! (Why?)

Latest stock market news from Wall Street – CNNMoney.com

You May Also Like

Leave a Reply

Your email address will not be published. Required fields are marked *